Phase I Trial Using Weekly Administration of Gemcitabine and Docetaxel in Patients with Advanced Pancreatic Carcinoma

Publisher： Karger

E-ISSN： 1421-9794|50|6|289-296

ISSN： 0009-3157

Source： Chemotherapy, Vol.50, Iss.6, 2004-12, pp. : 289-296

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A Phase I Study of Oral Uracil-Tegafur Prior to Weekly Intravenous Gemcitabine in Patients with Advanced Pancreatic Cancer

By  

Chemotherapy, Vol. 52, Iss. 2, 2006-04 ,pp. : 98-102

Karger

Access to resources Recommend Favorite

Phase I Trial of Gemcitabine Combined with Capecitabine and Erlotinib in Advanced Pancreatic Cancer: A Clinical and Pharmacological Study

By  

Chemotherapy, Vol. 58, Iss. 5, 2012-12 ,pp. : 371-380

Karger

Access to resources Recommend Favorite

A Dose Escalation Trial of Biweekly Docetaxel and Gemcitabine with Filgrastim or Pegfilgrastim for the Treatment of Patients with Advanced Solid Tumors

By  

Chemotherapy, Vol. 56, Iss. 2, 2010-04 ,pp. : 135-141

Karger

Access to resources Recommend Favorite

Phase I Study of Weekly Irinotecan Combined with Weekly Cisplatin in Patients with Advanced Solid Tumors

By  

Chemotherapy, Vol. 48, Iss. 4, 2002-09 ,pp. : 205-210

Karger

Access to resources Recommend Favorite

Salvage Therapy with Mitomycin and Ifosfamide in Patients with Gemcitabine-Resistant Metastatic Pancreatic Cancer: A Phase II Trial

By  

Chemotherapy, Vol. 57, Iss. 2, 2011-03 ,pp. : 156-161

Karger

Access to resources Recommend Favorite